prev next front |1 |2 |3 |4 |5 |6 |7 |8 |9 |10 |11 |12 |13 |14 |15 |16 |17 |18 |19 |20 |21 |22 |23 |24 |25 |26 |27 |review
Potential effective therapies are to improve survival, increase quality of life, and prevent recurring myocardial infarction.

It is not until you start getting down to the therapies that are actually addressing underlying vascular biology of coronary heart disease and other vascular diseases.

QOL: quality of life
PTCA: Pericutaneous Transluminal Coronary Angioplasty
CABG: Coronary Artery Bypass Graft
ACEI: Angiotensin converting enzyme inhibitor
ASA: Acetyl Salicylic Acid (Aspirin)